7+3 (chemotherapy)
id:
7-3-chemotherapy-300-17748096
title:
7+3 (chemotherapy)
text:
"7+3" in the context of chemotherapy is an acronym for a chemotherapy regimen that is most often used today as first-line induction therapy in acute myelogenous leukemia, excluding the acute promyelocytic leukemia form, which is better treated with ATRA and/or arsenic trioxide and requires less chemotherapy. The name "7+3" comes from the duration of chemotherapy course, which consists of 7 days of standard-dose cytarabine, and 3 days of an anthracycline antibiotic or an anthracenedione, most oft
brand slug:
wiki
category slug:
encyclopedia
description:
Acute myelogenous leukemia induction therapy regimen
original url:
https://en.wikipedia.org/wiki/7%2B3_(chemotherapy)
date created:
date modified:
2022-06-05T02:59:56Z
main entity:
{"identifier":"Q18040159","url":"https://www.wikidata.org/entity/Q18040159"}
image:
fields total:
13
integrity:
14